1Wong F, Blendis L. New challenge of hepatorenal syndrome: prevention and treatment. Hepatology, 2001, 34(6): 1242.
2Restuccia T,Ortega R,Guevara M,et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case -control study. Hepatology,2004,40(1):140.
3Solanki P, Chawla A, Garg R, et al. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo - controlled clinical trial. Gastroenterol Hepatol, 2003, 18(2): 152.
4Ortega R, Gines P, Uriz J, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective,nonrandomized study. Hepatology,2002,36(1):941.
5Duvoux C, Zanditenas D, Hezode C,et al. Noradrenalin for treatment of type 1 hepatorenal syndrome(HRS).Hepatology,2001, 34(1): 18.
6Angeli P, Volpin R. Gerunda G, et al. Reversal of type 1 hepatorenalsyndrome with the administration of midodrine and octreotide. Hepatology,1999, 29(6): 1690.
7Popescu A, Voiculescu M. Association of a selective endothelin - a receptor antagonist(ET- A RA) could improve the outcome of patients with hepatorenal syndrome(HRS).Hepatology, 2004, 40(1):71.
8Mitzner SR, Klammt S,Peszynski P, et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Therapeutic apheresis,2001,5(5) :417.
9Testino G, Ferro C, Sumberaz A, et al. Type - 2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stentshunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Gastroenterol Hepatol,2003, 50(54): 1753.
10Arroyo V,Guevara M,Gines P. Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. Gastroenterology, 2002, 122(6):1658.
